iohexol has been researched along with epirubicin in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Brambs, HJ; Claussen, CD; Dette, S; Dietz, K; Duda, SH; Geissler, F; Huppert, PE; Lauchart, W | 1 |
Kanematsu, M | 1 |
Asada, S; Doi, H; Goto, H; Imaeda, T; Kanematsu, M; Matsui, E; Mochizuki, R; Shibayama, M; Yamawaki, Y | 1 |
Ikoma, A; Kawai, N; Minamiguchi, H; Nakai, M; Nakata, K; Sahara, S; Sanda, H; Sato, M; Shirai, S; Sonomura, T; Tanaka, T | 1 |
Clasen, S; Claussen, CD; Hoffmann, R; Ketelsen, D; Pereira, PL; Rempp, H; Syha, R | 1 |
Hamamoto, S; Hamuro, M; Jogo, A; Kageyama, K; Miki, Y; Minami, T; Nakano, MM; Nishida, N; Sohgawa, E; Yamamoto, A | 1 |
1 trial(s) available for iohexol and epirubicin
Article | Year |
---|---|
Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Angiography; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Cisplatin; Contrast Media; Endpoint Determination; Epirubicin; Female; Fluorouracil; Humans; Iohexol; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
7 other study(ies) available for iohexol and epirubicin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[The chemoembolization of hepatocellular carcinoma: the computed tomographic findings and clinical results in prospective repetitive therapy].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clinical Protocols; Contrast Media; Epirubicin; Female; Humans; Iodized Oil; Iohexol; Liver Neoplasms; Male; Middle Aged; Palliative Care; Prospective Studies; Remission Induction; Retrospective Studies; Tomography, X-Ray Computed | 1994 |
Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization, Peripheral; Emulsions; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Iodized Oil; Iohexol; Liver Neoplasms; Male; Middle Aged; Mitomycin; Retrospective Studies | 1995 |
[Superselective bronchial arterial infusion therapy with cisplatin and epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hilar lung adenocarcinoma: preliminary clinical experience].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Cisplatin; Epirubicin; Humans; Infusions, Intra-Arterial; Iodized Oil; Iohexol; Lung Neoplasms; Male; Mitomycins | 1993 |
Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Contrast Media; Epirubicin; Female; Humans; Iohexol; Liver Neoplasms; Magnetic Resonance Imaging, Interventional; Male; Microspheres; Organometallic Compounds; Retrospective Studies; Survival Rate; Treatment Outcome | 2014 |
Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE).
Topics: Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Female; Humans; Iohexol; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiographic Image Enhancement; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome | 2019 |